Feature | November 04, 2010

Prostate MRI Analysis and Intervention Following Multiple Negative TRUS Biopsies: A Case Study

Multiplanar T2-weighted images and ADC map.

DynaCAD for Prostate and DynaTRIM interventional planning.

Prostate disease is primarily evaluated by using digital rectal examination (DRE) in combination with other clinical data including prostate-specific antigen (PSA) tests and pathologic information. These commonly used diagnostic tests have been shown to result in both high false positive and high false negative results. Additionally, the use of transrectal ultrasound-guided (TRUS) biopsy techniques for cancer detection can miss 20 percent or more of prostate cancers.

The use of DynaCAD for Prostate for image analysis and DynaTRIM (Trans-Rectal Interventional MRI) is a new option for evaluation of prostate disease, providing radiologists and urologists with another tool to diagnose their patients.

Clinical Case Study With Elevated PSA

A 67-year-old man presented with a PSA level of 5.4 ng/ml and no palpable abnormality on DRE. The first of two TRUS biopsies was performed with eight core samples. No malignancy was found. Due to elevated PSA, follow up was recommended.

Six months later, the second TRUS biopsy was performed with 12 core samples. Again, no malignancy was found and follow up was once again recommended. DRE was also performed with no palpable abnormalities. Since his PSA levels remained elevated, the patient was referred for a diagnostic MRI study. The examination was performed on a 3.0T MRI scanner with the body array coil in a dual-coil setup. Multiparametric imaging sequences were acquired including high-resolution, multiplanar T2-weighted anatomical images.

Diffusion-weighted images with b-values of 50, 500 and 800 were acquired and an ADC map was generated. The study was then imported to DynaCAD for Prostate for analysis and interpretation.

Image Results: A suspicious area was identified on axial T2. Based on these findings, MR-guided biopsy was recommended. MR-guided prostate biopsy was performed with DynaCAD for Prostate and DynaTRIM.

Diagnosis: Confirmed prostate pancer - Gleason 7 (75 percent in one core).

Summary: This patient, presenting with an elevated PSA, was able to benefit from this new imaging and interventional option where multiple TRUS-guided biopsies were performed with negative results. The clinician utilized DynaCAD for Prostate for the image analysis, which drew attention to suspicious areas and DynaTRIM for the targeted biopsy which resulted in a confirmed diagnosis.

This case study was supplied by Invivo Corp.

For more information: www.invivo.com, www.admetech.org and http://urology.jhu.edu/newsletter/prostate_cancer58.php

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
Technology | Magnetic Resonance Imaging (MRI) | June 27, 2018
June 27, 2018 — Zetta Medical Technologies announced the release of Zoom, its latest...
Children with Kidney Disease Show Blood Flow Changes in Brain
News | Neuro Imaging | June 25, 2018
Blood flow changes in the brains of children, adolescents and young adults with chronic kidney disease may explain why...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.


News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
Overlay Init